Design of Safe Nanotherapeutics for the Excretion of Excess Systemic Toxic Iron

[Image: see text] Chronic transfusion of red blood cells (RBCs) to patients with β-thalassemia, sickle cell disease, and other acquired anemic disorders generates significant amounts of bioactive iron deposits in the body. The inactivation and excretion of redox active iron(III) from the blood pool...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbina, Srinivas, Abbasi, Usama, Gill, Arshdeep, Wong, Kendrew, Kalathottukaren, Manu Thomas, Kizhakkedathu, Jayachandran N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2019
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535967/
https://www.ncbi.nlm.nih.gov/pubmed/31139728
http://dx.doi.org/10.1021/acscentsci.9b00284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535967/
https://www.ncbi.nlm.nih.gov/pubmed/31139728
http://dx.doi.org/10.1021/acscentsci.9b00284

Ejemplares similares